Concepedia

Author

Guo-Liang Yu

Human Genome Sciences (United States)

Also Known As

Guo-Liang Yu, Guo-liang Yu

7

Publications

2.6K

Citations

7

H-Index

22

Concepts

All Affiliations

Human Genome Sciences (United States)University of MichiganThe University of Texas MD Anderson Cancer CenterMolecular Oncology (United States)
GY

About

Guo-Liang Yu is an author at Human Genome Sciences (United States) specializing in immunology, medicine, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

273

2

Immunology

3

3

273

3

Cell Biology

2

2

116

4

Natural Sciences

1

1

157

5

Biomolecular Engineering

1

1

157

Guo-Liang Yu

×

7

Publications

2.6K

Citations

7

H-Index

YearCitations

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

Guohua Pan, Jian Ni, Ying-Fei Wei,

Science

1997

1.5K

Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95

Arul M. Chinnaiyan, Karen O’Rourke, Guo-Liang Yu,

Science

1996

653

Measuring affinity constants of 1450 monoclonal antibodies to peptide targets with a microarray-based label-free assay platform

J. P. Landry, Yaohuang Ke, Guo-Liang Yu,

Journal of Immunological Methods

2014

157

Cutting Edge: TRANK, a Novel Cytokine That Activates NF-κB and c-Jun N-Terminal Kinase

Valsala Haridas, Jian Ni, Anthony Meager,

The Journal of Immunology

1998

101

Inhibition of angiogenesis and breast cancer xenograft tumor growth by vegi, a novel cytokine of the tnf superfamily

Yifan Zhai, Jingyi Yu, M. Luisa Iruela‐Arispe,

International Journal of Cancer

1999

81

VEGI, a new member of the TNF family activates Nuclear Factor-κB and c-Jun N-terminal kinase and modulates cell growth

Valsala Haridas, Anju Shrivastava, Jeffrey Su,

Oncogene

1999

60

A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models

Yanlan Yu, Pierre Lee, Yaohuang Ke,

PLoS ONE

2010

56

Page 1